University of Kansas Cancer Center

Site:	University of Kansas Cancer Center
Address:
City:	Westwood
State:	KS
Zip:	66205
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)	Completed	Closed	Nilotinib or Imatinib	NCT00785785
2	Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study	Active, not recruiting	Closed	CB-839	NCT03872427